ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases. 

Biotechnology

ReCode Therapeutics

Shehnaaz Suliman

Erica V. Jefferson

John G. Matthews

Joe Cefalu

Teri Keffer

Rana Al-Hallaq

Marina Matkova Ristov

Eneda Hoxha

DeJuan L. Owens

Daniel Siegwart

Heather Clark

Shuang Li

Sakya Mohapatra

April Loui

David J Lockhart

Vladimir G. Kharitonov

Angèle Maki

The Business Development & Strategy team at ReCode Therapeutics is responsible for identifying and executing growth opportunities, forging strategic partnerships, overseeing financial planning, managing legal and intellectual property matters, and driving the overall business strategy to advance the company's mission of developing therapies for life-limiting respiratory diseases.

Business Development & Strategy

Research and Development

Directors Team

Leadership Team

Business Development & Strategy

About

Team members

Other teams at ReCode Therapeutics

Research and Development

Directors Team

Leadership Team